The Company intends to use the net proceeds from this offering to fund Immuron’s
Research and Development, preclinical and clinical programs, support marketing initiatives
surrounding the Company’s flagship product Travelan and provide ongoing working capital for the
Company.
apparently
- Forums
- ASX - By Stock
- Ann: Annual Report to shareholders
The Company intends to use the net proceeds from this offering...
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
8.6¢ |
Change
0.001(1.18%) |
Mkt cap ! $19.60M |
Open | High | Low | Value | Volume |
8.5¢ | 8.6¢ | 8.5¢ | $3.74K | 43.81K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 87972 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 11610 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6804 | 0.085 |
1 | 35585 | 0.084 |
1 | 17857 | 0.083 |
2 | 57388 | 0.081 |
6 | 150750 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 11610 | 2 |
0.089 | 703 | 1 |
0.094 | 164287 | 1 |
0.100 | 60500 | 2 |
0.105 | 27018 | 3 |
Last trade - 15.55pm 12/07/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |